Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE

C. Bárcena, C. Bárcena, A. Sra, J. Gao, J. Gao
Published 2003 · Materials Science

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The physical principles underlying some current biomedical applications of magnetic nanoparticles are reviewed. Starting from well-known basic concepts, and drawing on examples from biology and biomedicine, the relevant physics of magnetic materials and their responses to applied magnetic fields are surveyed. The way these properties are controlled and used is illustrated with reference to (i) magnetic separation of labelled cells and other biological entities; (ii) therapeutic drug, gene and radionuclide delivery; (iii) radio frequency methods for the catabolism of tumours via hyperthermia; and (iv) contrast enhancement agents for magnetic resonance imaging applications. Future prospects are also discussed.
This paper references
10.1002/CYTO.10071
Monitoring tumour cells in the peripheral blood of small cell lung cancer patients.
B. Kularatne (2002)
10.1021/JA961807N
Sonochemical Synthesis of Iron Colloids
K. Suslick (1996)
10.1016/0730-725X(95)02106-4
In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI.
L. Tiefenauer (1996)
10.1016/S0006-3495(99)77225-5
Measurement of local viscoelasticity and forces in living cells by magnetic tweezers.
A. Bausch (1999)
[Studies on liposomal ferromagnetic particles and a technique of high frequency inductive heating--in vivo studies of rabbits].
S. Suzuki (1990)
10.1073/PNAS.96.26.15256
Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination.
J. Bulte (1999)
10.1002/(SICI)1522-2586(199902)9:2<329::AID-JMRI27>3.0.CO;2-Z
Short‐ vs. long‐circulating magnetoliposomes as bone marrow‐seeking MR contrast agents
J. Bulte (1999)
MAGHEMITE@SILICA NANOPARTICLES FOR BIOLOGICAL APPLICATIONS
S. Mornet (2002)
Silica coating of Cobalt nanoparticles increases their magnetic and chemical stability for biomedical applications
J. Connolly (2002)
10.1006/JCIS.1997.5125
Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid
Fauconnier (1997)
10.1002/MRM.1910120202
Monoclonal antibody‐coated magnetite particles as contrast agents in magnetic resonance imaging of tumors
S. Cerdán (1989)
10.1021/JA0380852
Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles.
S. Sun (2004)
10.1097/00002142-200212000-00003
Oral Contrast Agents for Magnetic Resonance Imaging of the Bowel
A. Laghi (2002)
A simple method for coupling proteins to insoluble polysaccharides.
C. Sanderson (1971)
10.1007/s00330-004-2445-7
MRI after magnetic drug targeting in patients with advanced solid malignant tumors
A. Lemke (2004)
10.1111/J.1470-8744.1995.TB00339.X
Preparation and characteristics of magnetite‐labelled antibody with the use of poly(ethylene glycol) derivatives
M. Suzuki (1995)
10.1016/S0304-8853(99)00088-8
Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles
A. Jordan (1999)
10.1002/AOC.753
Superparamagnetic iron oxide particles: contrast media for magnetic resonance imaging
R. Lawaczeck (2004)
10.1016/0730-725X(94)92196-2
A comparative study between Gd-DTPA and oral magnetic particles (OMP) as gastrointestinal (GI) contrast agents for MRI of the abdomen.
L. Vlahos (1994)
10.1148/RADIOLOGY.218.1.R01JA2427
Contrast agents for MR imaging of the liver.
R. Semelka (2001)
10.1056/NEJMOA022749
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
M. Harisinghani (2003)
10.1002/MRM.1910290504
Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties
T. Shen (1993)
10.1023/B:JMSM.0000021126.32934.20
Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture
A. Gupta (2004)
10.1007/BF01059115
Targeting anticancer drugs to the brain: II. Physiological pharmacokinetic model of oxantrazole following intraarterial administration to rat glioma-2 (RG-2) bearing rats
J. Gallo (2005)
10.1148/RADIOLOGY.193.2.7972773
Pancreatic receptors: initial feasibility studies with a targeted contrast agent for MR imaging.
P. Reimer (1994)
10.1016/0969-8051(94)00124-3
Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results.
U. Häfeli (1995)
Magnetic resonance molecular imaging of the HER-2/neu receptor.
D. Artemov (2003)
10.1016/S0142-9612(01)00267-8
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake.
Y. Zhang (2002)
10.1007/s003300050535
Hepatic MRI with SPIO: detection and characterization of focal liver lesions
P. Reimer (1998)
Questions & answers in magnetic resonance imaging
A. Elster (1994)
10.3109/02656739409009328
Effect of hyperthermia on the central nervous system: a review.
P. Sminia (1994)
10.1016/S0378-4347(96)00199-5
Affinity chromatography of human anti-dextran antibodies. Isolation of two distinct populations.
S. Anastase (1996)
10.1016/0730-725X(95)00024-B
Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
C. W. Jung (1995)
10.1016/S0304-8853(02)00706-0
Heating magnetic fluid with alternating magnetic field
R. E. Rosensweig (2002)
10.1080/02656730110103519
Treatment of experimental rabbit liver tumours by selectively targeted hyperthermia
S. Jones (2002)
10.3892/IJO.18.1.121
Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters.
T. Kubo (2001)
10.1097/00000658-197311000-00021
Ferromagnetic Silicone Vascular Occlusion: A Technic for Selective Infarction of Tumors and Organs
J. A. Mosso (1973)
10.1023/A:1013901625389
Problems in the Local Hyperthermia of Inductively Heated Embolized Tissues
A. Granov (2002)
10.1016/S0167-4889(98)00002-0
Measuring transferrin receptor gene expression by NMR imaging.
A. Moore (1998)
10.1007/s00330-004-2570-3
Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging
Y. K. Kim (2004)
10.1002/JSO.1118
Targeting liver tumors with hyperthermia: Ferromagnetic embolization in a rabbit liver tumor model
P. Moroz (2001)
Mechanical conditioning of bone cells in vitro using magnetic microparticle technology
S. Cartmell (2002)
10.1016/0730-725X(86)91045-3
Immunospecific NMR contrast agents.
P. Renshaw (1986)
10.1148/RADIOLOGY.204.3.9280254
MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties.
A. Kopp (1997)
10.1002/MRM.1910400209
Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in Vivo by using transferrin receptor pathways
M. Kresse (1998)
10.1557/JMR.1998.0407
Monodisperse magnetic nanoparticles: preparation and dispersion in water and oils
S. Lefebure (1998)
10.1148/RADIOLOGY.175.2.2326474
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
R. Weissleder (1990)
10.1007/s00330-004-2405-2
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
S. Metz (2004)
[Experimental study of ferromagnetic induction heating combined with hepatic arterial embolization for treatment of liver tumors].
M. Hase (1990)
10.1002/jmri.1086
A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution
L. Johansson (2001)
10.1016/S0378-5173(01)00936-X
Development and characterization of solid lipid nanoparticles loaded with magnetite.
M. Igartua (2002)
10.1088/0031-9155/40/4/012
Detection and counting of specific cell populations by means of magnetic markers linked to monoclonal antibodies.
C. Del Gratta (1995)
10.1016/S0304-8853(00)01226-9
Structural and magnetic properties of nanoscale iron oxide particles synthesized in the presence of dextran or polyvinyl alcohol
H. Pardoe (2001)
10.1021/NL034731J
“Pulling” Nanoparticles into Water: Phase Transfer of Oleic Acid Stabilized Monodisperse Nanoparticles into Aqueous Solutions of α-Cyclodextrin
Y. Wang (2003)
10.3109/10611869808997890
Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review.
B. Bonnemain (1998)
10.1109/TNB.2003.820277
Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies
A. Gupta (2004)
10.1016/S0304-8853(99)00005-0
Immobilization of proteins and enzymes to fine magnetic particles
M. Koneracká (1999)
10.1016/S0956-5663(99)00054-8
The BARC biosensor applied to the detection of biological warfare agents.
R. Edelstein (2000)
10.1002/JMRI.1880040313
Phase I clinical evaluation of a new iron oxide MR contrast agent
S. McLachlan (1994)
10.1016/0304-8853(94)00793-4
Magnetic properties of γ-Fe2O3 small particles prepared by spray pyrolysis
A. López (1995)
10.1109/TMAG.1981.1061711
A bench top magnetic separator for malarial parasite concentration
F. Paul (1981)
10.1161/01.CIR.103.3.415
Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits
S. Ruehm (2001)
10.1182/BLOOD-2004-06-2222
Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model.
S. Anderson (2005)
10.1002/JMRI.1880030118
Contribution of oral magnetic particles in MR imaging of the abdomen with spin‐echo and gradient‐echo sequences
Frank P. Boudghëne (1993)
10.1023/A:1015590930284
Accelerated simulation of heat transfer in magnetic fluid hyperthermia
V. Craciun (2002)
10.1016/0304-8853(93)91113-L
Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer
D. Chan (1993)
10.1016/S0140-6736(84)90004-7
REMOVAL OF NEUROBLASTOMA CELLS FROM BONE MARROW WITH MONOCLONAL ANTIBODIES CONJUGATED TO MAGNETIC MICROSPHERES
J. Treleaven (1984)
10.1002/(SICI)1097-0215(19980209)75:4<626::AID-IJC22>3.0.CO;2-5
Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti‐epidermal growth factor receptor antibody
Toshikazu Suwa (1998)
10.1038/nbt1201-1141
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
J. Bulte (2001)
10.1148/RADIOL.2293021215
Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.
A. Arbab (2003)
10.1016/0304-8853(93)91063-D
Relaxation and resonance in ferrofluids
P. C. Fannin (1993)
10.1002/mrm.10066
Assessment of T1 and T  *2 effects in vivo and ex vivo using iron oxide nanoparticles in steady state—dependence on blood volume and water exchange
A. Bjørnerud (2002)
10.1016/S0921-5093(00)00628-6
Investigations on magnetic properties and structure for carbon encapsulated nanoparticles of Fe, Co, Ni
X. Sun (2000)
10.1016/0169-409X(88)90010-5
Bone marrow purging: an appraisal of immunological and non-immunological methods
J. Treleaven (1988)
10.1080/09553008814552561
Effects of local hyperthermia on the motor function of the rat sciatic nerve.
J. Wondergem (1988)
10.1016/S0304-8853(00)01264-6
Glial brain tumor targeting of magnetite nanoparticles in rats
O. Mykhaylyk (2001)
10.1002/MRM.1910250115
Specific MR imaging of human lymphocytes by monoclonal antibody‐guided dextran‐magnetite particles
Jeff W. M. Bulte (1992)
10.1021/JA045911D
Shape-controlled synthesis and shape-induced texture of MnFe2O4 nanoparticles.
H. Zeng (2004)
10.1021/JP027048E
Magnetite Fe3O4 Nanocrystals: Spectroscopic Observation of Aqueous Oxidation Kinetics†
J. Tang (2003)
10.1080/02656730110108785
Magnetically mediated hyperthermia: current status and future directions
P. Moroz (2002)
10.1021/CM960157J
Synthesis and Characterization of Nanometer-Size Fe3O4 and γ-Fe2O3 Particles
Y. Kang (1996)
10.1016/S0304-8853(00)01238-5
Evaluation of ferromagnetic fluids and suspensions for the site-specific radiofrequency-induced hyperthermia of MX11 sarcoma cells in vitro
N. A. Brusentsov (2001)
10.1016/S0272-6386(96)90463-1
The safety of intravenous iron dextran in hemodialysis patients.
S. Fishbane (1996)
10.1182/BLOOD.V100.10.3553
Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow.
W. Hofmann (2002)
MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis.
L. G. Remsen (1996)
10.1006/JCIS.1998.6053
Synthesis of Iron Oxide Nanoparticles Used as MRI Contrast Agents: A Parametric Study.
Babes (1999)
10.1016/J.MEHY.2004.07.033
Improved drug delivery to cancer cells: a method using magnetoliposomes that target epidermal growth factor receptors.
M. Kullberg (2005)
10.1016/0001-8686(94)00227-4
Preparation of nanoparticles of silver halides, superconductors and magnetic materials using water-in-oil microemulsions as nano-reactors
V. Pillai (1995)
10.1148/RADIOL.2251011090
Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver.
A. Arbab (2002)
10.3892/IJO.17.2.309
Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters.
T. Kubo (2000)
10.1097/00004728-200109000-00017
Splenic Imaging with Ultrasmall Superparamagnetic Iron Oxide Ferumoxtran-10 (AMI-7227): Preliminary Observations
M. Harisinghani (2001)
10.1097/00000658-195710000-00007
Selective Inductive Heating of Lymph Nodes
R. Gilchrist (1957)
10.1089/104303404322959506
In vivo trafficking and targeted delivery of magnetically labeled stem cells.
A. Arbab (2004)
10.1006/JCIS.2001.7579
Synthesis and Characterization of Spherical Magnetite/Biodegradable Polymer Composite Particles.
S. A. Gómez-Lopera (2001)
10.1016/0304-8853(95)00317-7
Synthesis of very fine maghemite particles
A. Bee (1995)
10.3109/10611869808997896
Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres.
S. K. Pulfer (1998)
10.1126/SCIENCE.277.5330.1232
Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites
Gero Decher (1997)
10.1016/S0304-8853(98)00584-8
Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy
S. Goodwin (1999)
10.1016/S0304-8853(00)01253-1
Multistage magnetic particle separator
P. Todd (2001)
10.1126/SCIENCE.7684161
Mechanotransduction across the cell surface and through the cytoskeleton
Ning Wang (1993)
10.1097/01.TP.0000145528.51525.8B
Noninvasive Monitoring and Tracking of Muscle Stem Cell Transplants
Kevin S. Cahill (2004)
10.1016/S0304-8853(98)00561-7
New types of silica-fortified magnetic nanoparticles as tools for molecular biology applications
C. Gruettner (1999)
10.1088/0967-3334/20/3/701
Magnetism in medicine : a handbook
W. Vennart (1999)
10.1016/S0304-8853(00)01222-1
Iron nanoparticles as potential magnetic carriers
E. Carpenter (2001)
10.1073/PNAS.76.7.3392
Iron-dextran antibody conjugates: General method for simultaneous staining of two components in high-resolution immunoelectron microscopy.
A. Dutton (1979)
10.1049/sqj.1967.0017
Physical principles of magnetism
F. Brailsford (1966)
An introduction to the practical aspects of clinical hyperthermia
S. B. Field (1990)
10.1021/CM0203013
Nanochemistry: Synthesis and Characterization of Multifunctional Nanoclinics for Biological Applications
L. Lévy (2002)
10.1021/JA017773N
DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents.
J. M. Pérez (2002)
Ferrimagnetic susceptibility contrast agents.
T. Bach-Gansmo (1993)
10.2214/AJR.152.1.167
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
R. Weissleder (1989)
10.1109/MCTE.2002.1175016
Preliminary analysis of magnetic particle techniques for activating mechanotransduction in bone cells
S. Cartmell (2002)
10.1021/NL035172J
Hydrophobic Nanocrystals Coated with an Amphiphilic Polymer Shell: A General Route to Water Soluble Nanocrystals
T. Pellegrino (2004)
10.1016/S0304-8853(00)01230-0
Radiolabeling of magnetic particles with rhenium-188 for cancer therapy
U. Häfeli (2001)
10.1002/1521-3773(20010817)40:16<3001::AID-ANIE3001>3.0.CO;2-5
Spontaneous phase transfer of nanoparticulate metals from organic to aqueous media.
D. Gittins (2001)
10.1016/S0378-1135(98)00193-X
Rapid and sensitive detection of Staphylococcus species in milk by ELISA based on monodisperse magnetic particles.
S. Yazdankhah (1998)
10.1038/73219
In vivo magnetic resonance imaging of transgene expression
R. Weissleder (2000)
10.1006/MTHE.2001.0268
Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors.
C. Hughes (2001)
10.1148/RADIOL.2252011605
Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.
S. C. Michel (2002)
10.3109/02656739409012371
Development of intra-arterial hyperthermia using a dextran-magnetite complex.
M. Mitsumori (1994)
10.1016/S0142-9612(00)00006-5
Preparation, characterization, and performance of magnetic iron-carbon composite microparticles for chemotherapy.
S. Rudge (2000)
10.1021/BC0155521
Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture.
H. W. Kang (2002)
10.1006/MTHE.2001.0636
Improved method of recombinant AAV2 delivery for systemic targeted gene therapy.
C. Mah (2002)
10.1148/RADIOLOGY.177.3.2243978
Receptor imaging: application to MR imaging of liver cancer.
P. Reimer (1990)
10.3109/02656739709023559
Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
A. Jordan (1997)
10.1148/RADIOL.2333031714
In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver.
C. Bos (2004)
10.1016/S1381-1177(02)00016-4
Direct binding procedure of proteins and enzymes to fine magnetic particles
M. Koneracká (2002)
10.1016/0014-5793(79)80940-0
Preparation and application of magnetic polymers for targeting of drugs
K. Mosbach (1979)
10.1016/S0304-8853(98)00564-2
Implications of heterogeneous bead behavior on cell mechanical properties measured with magnetic twisting cytometry
B. Fabry (1999)
10.1023/A:1006137523591
Distribution of Small Magnetic Particles in Brain Tumor-bearing Rats
S. K. Pulfer (2004)
10.2214/AJR.155.6.2122660
MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors.
R. Weissleder (1990)
Preclinical experiences with magnetic drug targeting: tolerance and efficacy.
A. Lübbe (1996)
10.1056/NEJMP030048
New horizons in oncologic imaging.
D. Koh (2003)
Historic publication on the first use of magnets in orthodontics.
Duterloo Hs (1995)
10.1088/0031-9155/37/1/023
Evaluation of ferromagnetic materials for low-frequency hysteresis heating of tumours.
S. Jones (1992)
10.1096/fj.02-1124fje
In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies
I. Pirko (2004)
In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors.
M. Kircher (2003)
10.3892/IJO.16.6.1153
Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats.
T. Minamimura (2000)
10.1016/S0360-3016(98)00554-9
Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres.
U. Häfeli (1999)
10.1161/01.CIR.0000070931.62772.4E
In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction
D. Kraitchman (2003)
10.1148/RADIOL.2262011815
MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
F. Wacker (2003)
10.1016/S0022-1759(01)00546-4
Immunopurification of Golgi vesicles by magnetic sorting.
C. V. Mura (2002)
10.1080/02656730110116713
Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense?
Y. Rabin (2002)
10.1016/0277-5379(83)90408-X
Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
K. Widder (1983)
10.1038/70761
Optical tracking and detection of immunomagnetically selected and aligned cells
A. Tibbe (1999)
10.1021/BC000079X
Improvement of MRI probes to allow efficient detection of gene expression.
D. Högemann (2000)
10.1021/BC980125H
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.
L. Josephson (1999)
10.1063/1.370256
A new method for the synthesis of magnetoliposomes
C. Sangregorio (1999)
10.1021/BC00023A007
Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging.
L. Tiefenauer (1993)
10.1002/mrm.10406
MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles
D. Artemov (2003)
10.1016/S1359-0286(02)00117-1
Biodegradable nanoparticles for drug delivery and targeting
M. Hans (2002)
10.1007/978-3-642-82215-5
Basic principles and applications
C. A. Brebbia (1984)
10.1126/science.171.3976.1151
Tumor Detection by Nuclear Magnetic Resonance
R. Damadian (1971)
10.1023/A:1018457915380
Direct binding of protein to magnetic particles
R. V. Mehta (1997)
10.1016/0304-8853(91)90617-J
The frequency dependence of the complex susceptibility of magnetic liquids
M. Hanson (1991)
10.1016/S0304-8853(00)01227-0
Magnetic cobalt dispersions in poly(dimethylsiloxane) fluids
J. P. Stevenson (2001)
10.1073/pnas.242435499
Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat
M. Hoehn (2002)
10.1148/RADIOLOGY.181.1.1887040
Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging.
R. Weissleder (1991)
10.1016/0921-5093(94)90865-6
Temperature-sensitive amorphous magnetic flakes for intratissue hyperthermia
H. Matsuki (1994)
10.1016/S0167-7012(02)00046-5
Immunomagnetic separation of scum-forming bacteria using polyclonal antibody that recognizes mycolic acids.
S. Morisada (2002)
10.1097/00004424-199510000-00006
Cellular Uptake and Trafficking of a Prototypical Magnetic Iron Oxide Label In Vitro
E. Schulze (1995)
10.1002/jmri.1224
Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A)
D. Kehagias (2001)
10.1016/S0304-8853(98)00586-1
Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study.
M. Yanase (1998)
10.1002/jmri.10425
Ferumoxide‐enhanced MR imaging of hepatocellular carcinoma: Correlation with histologic tumor grade and tumor vascularity
H. Kato (2004)
10.1016/S0009-9260(05)81159-6
Phase III trial of oral magnetic particles in MRI of abdomen and pelvis.
D. Macvicar (1993)
10.1016/S0304-8853(00)01251-8
Progenitor cell isolation with a high-capacity quadrupole magnetic flow sorter
L. Moore (2001)
10.1016/0360-3016(83)90074-3
Hyperthermia by magnetic induction: II. Clinical experience with concentric electrodes.
J. Oleson (1983)
10.1016/S0304-8853(02)00605-4
Magnetic drug targeting: biodistribution and dependency on magnetic field strength ☆
Ch. Alexiou (2002)
10.1016/0022-1759(82)90007-2
Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells.
R. Molday (1982)
10.1080/02656730410001714977
A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery
M. Albregts (2004)
10.1016/J.BIOMATERIALS.2004.05.022
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
10.1093/ANNONC/MDF280
Heating the patient: a promising approach?
J. V. D. Zee (2002)
10.1103/PHYSREVLETT.87.148102
Scaling the microrheology of living cells.
B. Fabry (2001)
10.1016/S1470-2045(02)00818-5
Hyperthermia in combined treatment of cancer.
P. Wust (2002)
10.1063/1.881640
Driving Force: The Natural Magic of Magnets
J. Livingston (1996)
10.1148/RADIOLOGY.182.2.1732982
Receptor-directed contrast agents for MR imaging: preclinical evaluation with affinity assays.
P. Reimer (1992)
10.1111/j.1749-6632.1992.tb49600.x
Principles of Nerve and Heart Excitation by Time‐varying Magnetic Fields
J. Reilly (1992)
10.1016/S0304-8853(98)00560-5
In vitro and in vivo toxicity of magnetic microspheres
U. Häfeli (1999)
10.2307/3576083
Hyperthermia by magnetic induction: experimental and theoretical results for coaxial coil pairs.
J. Oleson (1983)
10.1016/S0304-8853(01)00386-9
Synthesis, magnetic properties, surface modification and cytotoxicity evaluation of Y3Fe5−xAlxO12 (0⩽x⩽2) garnet submicron particles for biomedical applications
F. Grasset (2001)
10.1016/0169-409X(95)00025-3
Long circulating microparticulate drug carriers
S. Stolnik (1995)
10.1002/mrm.20220
In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction
N. Himes (2004)
10.1038/nm1101-1241
Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent
M. Zhao (2001)
10.1016/S0304-8853(98)00562-9
Synthesis of silicone magnetic fluid for use in eye surgery
J. Dailey (1999)
10.1016/S0304-8853(00)01254-3
Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood
P. Liberti (2001)
10.1016/S0304-8853(02)00987-3
Preparation of magnetic polymeric particles via inverse microemulsion polymerization process
Y. Deng (2003)
10.1021/JP026042M
Synthesis of Highly Crystalline and Monodisperse Cobalt Ferrite Nanocrystals
T. Hyeon (2002)
10.4269/AJTMH.1997.56.322
An integrated system using immunomagnetic separation, polymerase chain reaction, and colorimetric detection for diagnosis of Plasmodium falciparum.
N. Seesod (1997)
10.1002/(SICI)1522-2586(199902)9:2<228::AID-JMRI12>3.0.CO;2-K
Improved delineation of human brain tumors on MR images using a long‐circulating, superparamagnetic iron oxide agent
W. S. Enochs (1999)
10.1016/S1076-6332(03)80171-X
Heating potential of iron oxides for therapeutic purposes in interventional radiology.
I. Hilger (2002)
10.1016/S1076-6332(03)00248-4
Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions.
H. Daldrup-Link (2003)
10.1016/S0006-3495(98)77646-5
Local measurements of viscoelastic parameters of adherent cell surfaces by magnetic bead microrheometry.
A. Bausch (1998)
10.1158/0008-5472.CAN-03-3230
In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe
A. Moore (2004)
10.1148/RADIOLOGY.175.3.2343116
First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging.
P. Hahn (1990)
10.1016/J.JMMM.2004.03.012
Application of high gradient magnetic separation principles to magnetic drug targeting
J. Ritter (2004)
10.1006/ABIO.1997.2378
Magnetic bead enzyme-linked immunosorbent assay (ELISA) detects antigen-specific binding by phage-displayed scFv antibodies that are not detected with conventional ELISA.
Mrinalini Kala (1997)
10.1562/0031-8655(2003)077<0431:TCTOTE>2.0.CO;2
Targeting Cells That Overexpress the Epidermal Growth Factor Receptor with Polyethylene Glycolated BPD Verteporfin Photosensitizer Immunoconjugates¶
M. D. Savellano (2003)
10.1162/15353500200403190
Comparison of Transfection Agents in Forming Complexes with Ferumoxides, Cell Labeling Efficiency, and Cellular Viability
A. Arbab (2004)
10.1002/AOC.155
Effect of the oxidation conditions on the maghemites produced by laser pyrolysis
S. Veintemillas-Verdaguer (2001)
10.1002/jnr.20041
Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord
P. Jendelová (2004)
10.1006/JSRE.2000.6030
Clinical applications of magnetic drug targeting.
A. Lübbe (2001)
10.1038/74464
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
M. Lewin (2000)
10.1201/9781439822081.CH8
Spatially Localised Nuclear Magnetic Resonance
M. Leach (1988)
10.1021/JA016812S
Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process.
T. Hyeon (2001)
10.1038/NMAT1251
Ultra-large-scale syntheses of monodisperse nanocrystals
J. Park (2004)
10.1021/BC015549H
High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes.
D. Högemann (2002)
10.1016/0254-0584(91)90125-E
Preparation of homogeneous mixed oxides by spray pyrolysis
T. Carreño (1991)
10.1063/1.325219
Magnetic guidance of drug‐carrying microspheres
A. Senyei (1978)
10.1016/S0022-5347(05)63996-1
Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro.
R. Zigeuner (2003)
10.1109/TBME.1984.325372
Usable Frequencies in Hyperthermia with Thermal Seeds
W. Atkinson (1984)
10.1002/JSO.1106
Status of hyperthermia in the treatment of advanced liver cancer
P. Moroz (2001)
Targeted hyperthermia using dextran magnetite complex: a new treatment modality for liver tumors.
M. Mitsumori (1996)
10.1016/S0927-7757(00)00538-0
Structured materials syntheses in a self-assembled surfactant mesophase
S. Li (2000)
10.1006/JSSC.2001.9426
Influence of grain size, oxygen stoichiometry, and synthesis conditions on the γ-Fe2O3 vacancies ordering and lattice parameters
T. Belin (2002)
10.1007/978-1-4757-6482-6_15
Physics of Magnetic Cell Sorting
Maciej Zborowski (1997)
10.1002/mrm.10529
Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging
Y. Wadghiri (2003)
10.1109/20.706388
Magnetic properties of a series of ferrite nanoparticles synthesized in reverse micelles
C. Seip (1998)
10.1016/0169-409X(95)00033-4
Long-circulating iron oxides for MR imaging
R. Weissleder (1995)
10.1021/JP049041Y
Direct synthesis of highly crystalline and monodisperse manganese ferrite nanocrystals
Eunae Kang (2004)
10.1093/TOXSCI/60.1.177
Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier.
S. Goodwin (2001)
10.1109/20.718537
Physical limits of hyperthermia using magnetite fine particles
R. Hergt (1998)
10.1007/s00330-002-1721-7
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
P. Reimer (2002)
10.1016/S0304-8853(98)00574-5
Physiological aspects in magnetic drug-targeting
A. Lübbe (1999)
10.1385/1-59259-873-0:291
Magnetic cell sorting.
Maciej Zborowski (2005)
10.1007/BF02798277
Thermomagnetic surgery for cancer
R. W. Rand (1981)
10.1063/1.1599959
Static and dynamic magnetic properties of spherical magnetite nanoparticles
G. F. Goya (2003)
Selective radiofrequency heating of ferrosilicone occluded tissue: a preliminary report.
R. W. Rand (1976)
10.1103/PHYSREV.130.1677
Thermal Fluctuations of a Single-Domain Particle
J. W. F. Brown (1963)
10.1088/0022-3727/24/1/013
Measurement of the Neel relaxation of magnetic particles in the frequency range 1 kHz to 160 MHz
P. C. Fannin (1991)
10.1080/02841859709174391
Magnetic Iron Oxide Particles Coated with Carboxydextran for Parenteral Administration and Liver Contrasting
R. Lawaczeck (1997)
Drug delivery by magnetic microspheres
G. Richardson (2000)
Pathological Effects of Hyperthermia in Normal Tissues
Luis Felipe Fajardo L-G (1984)
Behaviour of aqueous ferrofluids in presence of aminoacids
J. Roger (1989)
10.1088/0031-9155/29/5/001
Hysteresis heating for the treatment of tumours.
N. Borrelli (1984)
10.1016/J.JMMM.2004.04.035
Synthesis and characterization of superparamagnetic maghemite nanoparticles prepared by coprecipitation technique
S. Lee (2004)
10.1016/S1076-6332(03)80210-6
Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents.
P. Wunderbaldinger (2002)
10.1016/S0304-8853(00)00439-X
Magnetic fractionation of magnetic fluids
T. Rheinlaender (2000)
10.1021/BC960003U
Magnetically labeled secretin retains receptor affinity to pancreas acinar cells.
T. Shen (1996)
10.1148/RADIOL.2283020872
Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.
Y. Anzai (2003)
10.1148/RADIOLOGY.182.2.1732953
Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging.
R. Weissleder (1992)
10.1002/JMRI.1880070111
Iron oxide‐enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancer
Y. Anzai (1997)
10.1021/JA026501X
Size-controlled synthesis of magnetite nanoparticles.
S. Sun (2002)
Locoregional cancer treatment with magnetic drug targeting.
C. Alexiou (2000)
10.1143/JJAP.41.1620
Heating of Ferrite Powder by an AC Magnetic Field for Local Hyperthermia
Tsunehiro Maehara (2002)
10.1016/S0304-8853(00)01239-7
Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia
A. Jordan (2001)
10.1002/cbic.200300713
Surface‐Functionalized Nanoparticle Library Yields Probes for Apoptotic Cells
Eyk A Schellenberger (2004)
10.1016/J.MRI.2004.01.050
MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents.
M. Funovics (2004)
POLYSILOXANE FLUID DISPERSIONS OF COBALT NANOPARTICLES IN SILICA SPHERES FOR USE IN OPHTHALMIC APPLICATIONS
M. Rutnakornpituk (2002)
10.1016/S0304-8853(00)00198-0
Comparison of size-selective techniques for the fractionation of magnetic fluids
T. Rheinlaender (2000)
10.1259/0007-1285-66-785-420
Abdominal MRI using a negative contrast agent.
T. Bach-Gansmo (1993)
10.1016/0022-1759(93)90275-C
A rapid and highly selective approach to cell separations using an immunomagnetic colloid.
J. Hancock (1993)
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
A. Lübbe (1996)
10.1161/01.CIR.0000084537.66419.7A
Serial Cardiac Magnetic Resonance Imaging of Injected Mesenchymal Stem Cells
J. D. Hill (2003)
10.1016/S1076-6332(96)80222-4
Oral magnetic particles (ferristene) as a contrast medium in abdominal magnetic resonance imaging.
T. Jacobsen (1996)
10.1148/RADIOLOGY.192.3.7520182
Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer.
Y. Anzai (1994)
10.1021/LA0008636
Synthesis and Characterization of Silica-Coated Iron Oxide Nanoparticles in Microemulsion: The Effect of Nonionic Surfactants
S. Santra (2001)
10.1007/978-1-4757-6482-6_35
Selected Preclinical and First Clinical Experiences with Magnetically Targeted 4’-Epidoxorubicin in Patients with Advanced Solid Tumors
A. Lübbe (1997)
10.1021/JA993280V
A new nonhydrolytic single-precursor approach to surfactant-capped nanocrystals of transition metal oxides
J. Rockenberger (1999)
10.1109/TMAG.2003.816260
An approach to targeted drug delivery based on uniform magnetic fields
Z. G. Forbes (2003)
10.1016/S0304-8853(00)01250-6
Magnetic design considerations for devices and particles used for biological high-gradient magnetic separation (HGMS) systems
G. P. Hatch (2001)
10.1016/0306-9877(79)90063-X
Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations.
R. Gordon (1979)
10.1016/S0304-8853(00)01224-5
Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles
D. Kim (2001)
10.3181/00379727-158-40158
Magnetic Microspheres: A Model System for Site Specific Drug Delivery in Vivo 1
K. Widder (1978)
10.1007/978-1-4757-6482-6_38
Magnetically Targeted Microspheres for Intracavitary and Intraspinal Y-90 Radiotherapy
U. Häfeli (1997)
10.1002/NBM.924
Iron oxide MR contrast agents for molecular and cellular imaging
J. Bulte (2004)
10.1148/RADIOLOGY.168.2.3393649
Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.
David D. Stark (1988)
10.1097/01.rli.0000129472.45832.b0
Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging
M. Taupitz (2004)
10.1038/SJ.NEO.7900266
MRI of transgene expression: correlation to therapeutic gene expression.
T. Ichikawa (2002)
10.1016/S0168-3659(01)00519-3
Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core.
J. L. Arias (2001)
10.1021/BC0255236
Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake.
M. Zhao (2002)
10.1016/S0021-9290(02)00034-9
Hydrodynamics of magnetic drug targeting.
P. A. Voltairas (2002)
10.1038/nbt720
Magnetic relaxation switches capable of sensing molecular interactions
J. M. Pérez (2002)
10.1002/mrm.10684
Noninvasive monitoring of stem cell transfer for muscle disorders
G. Walter (2004)



This paper is referenced by
10.1016/j.watres.2009.05.046
Stabilization of highly concentrated suspensions of iron nanoparticles using shear-thinning gels of xanthan gum.
S. Comba (2009)
10.1007/S10751-009-9922-Y
Gummic acid stabilized γ-Fe2O3 aqueous suspensions for biomedical applications
G. Papaefthymiou (2009)
10.1118/1.2966595
Towards new functional nanostructures for medical imaging.
N. Matsuura (2008)
10.1016/J.JMMM.2011.11.022
Analysis of high gradient magnetic field effects on distribution of nanoparticles injected into pulsatile blood stream
Mohammad Reza Habibi (2012)
10.1260/1708-5284.9.2.161
Versatile low-pressure plasma-enhanced process for synthesis of iron and iron-based magnetic nanopowders
P. Zelina (2012)
10.1016/J.COCHE.2013.11.006
Metal ions in the context of nanoparticles toward biological applications
Carolina Carrillo-Carrión (2014)
10.1049/MNL.2014.0072
Theoretic optimisation of microfluidic and magnetic self-assembly of carbon nanotubes
Joon S Shim (2014)
10.1016/J.CCLET.2015.01.007
Highly efficient and regioselective thiocyanation of aromatic amines, anisols and activated phenols with H2O2/NH4SCN catalyzed by nanomagnetic Fe3O4
D. Khalili (2015)
10.1016/j.envres.2020.109433
Impacts of organic matter on the toxicity of biosynthesized silver nanoparticles to green microalgae Chlorella vulgaris.
M. Khoshnamvand (2020)
Developing a Halbach array for targeted drug delivery to brain tumours
A. Alghamdi (2020)
10.1166/JBN.2007.021
Microwave Response of La 0.7 Sr 0.3 MnO 3 Nanoparticles for Heating Applications
Sonia Kale (2007)
The Development of a Low-Cost Microfluidic Magnetic Separation System
G. Smith (2009)
Desarrollo de nanocompósitos Desarrollo de nanocompósitos Desarrollo de nanocompósitos Desarrollo de nanocompósitos Desarrollo de nanocompósitos superparamagnéticos de matriz biopolimérica superparamagnéticos de matriz biopolimérica superparamagnéticos de matriz biopolimérica superparamagnéticos de
Marco Garza (2009)
InAs Quantum Well Micro-Hall Devices for Magnetic Detection of Biomolecular Labels
Khaled Aledealat (2010)
10.2529/PIERS091218133748
Computational Modeling of Electromagnetically Induced Heating of Magnetic Nanoparticle Materials for Hyperthermic Cancer Treatment
L. Rast (2010)
10.1109/IEMBS.2010.5627353
Development of nanostructured magnetic capsules by means of the layer by layer technique
O. Herrera (2010)
10.1155/2012/610305
Structure and Magnetic Properties of Aerosol Nanoparticles of Fe and Its Alloys
Y. I. Petrov (2012)
10.1142/9789814520652_0010
Inorganic Nanopreparations for Nanomedicine
James Ramos (2014)
10.1088/2053-1591/2/7/075401
Toxicokinetics and biodistribution of dextran stabilized iron oxide nanoparticles in rats.
S. L. Easo (2015)
10.1002/jbm.b.33812
The combined effect of thermal and chemotherapy on HeLa cells using magnetically actuated smart textured fibrous system.
P. Tiwari (2018)
10.1179/1432891714Z.000000000543
Synchrotron X-ray absorption of iron oxides synthesised by ultrasound assisted coprecipitation: effects of temperature and surfactant
W. Tangwatanakul (2014)
10.1016/j.jhazmat.2014.05.011
Inactivation performance and mechanism of Escherichia coli in aqueous system exposed to iron oxide loaded graphene nanocomposites.
Can-Hui Deng (2014)
10.1016/J.JALLCOM.2016.03.279
Influence of crystallite size on the magnetic properties of Fe3O4 nanoparticles
Sneha Upadhyay (2016)
10.1088/0957-4484/27/15/155707
Enhanced magnetic anisotropy and heating efficiency in multi-functional manganese ferrite/graphene oxide nanostructures.
Anh-Tuan Le (2016)
10.1109/JETCAS.2016.2547700
Spintronic Memristor as Interface Between DNA and Solid State Devices
Jianlei Yang (2016)
10.1016/B978-0-08-101925-2.00004-8
Chapter 5 – Magnetic Particle Imaging (MPI)
S. Zanganeh (2018)
10.1016/J.SNB.2017.09.108
An InSb-based magnetoresistive biosensor using Fe3O4 nanoparticles
S. B. Kim (2018)
10.1002/mrd.22831
Novel agents for sperm purification, sorting, and imaging
J. Feugang (2017)
10.1021/ACSSENSORS.5B00318
Recent Development of Cardiac Troponin i Detection
X. Han (2016)
10.1016/j.biocel.2015.10.011
Overcoming translational challenges - The delivery of mechanical stimuli in vivo.
H. Markides (2015)
10.1016/J.JPCS.2015.08.005
Preparation of silica coated cobalt ferrite magnetic nanoparticles for the purification of histidine-tagged proteins
Gülfem Aygar (2015)
10.1016/J.DIAMOND.2015.12.009
Synthesis and properties of modified graphite encapsulated iron metal nanoparticles
Shang-Shih Li (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar